WASHINGTON, April 28 -- Sen. Maggie Hassan, D-New Hampshire, issued the following news release: * * * Congressional Delegation Presses for Urgent Risk Assessment of Portsmouth Memorial Bridge WASHINGTON, D.C. - Today Congressman Chris Pappas (NH-01), a member of the House Transportation and Infrastructure Committee, led Senator Jeanne Shaheen (NH), Senator Maggie Hassan (NH), and Congresswoman Maggie Goodlander (NH-02) in urging the Federal Highway Administration (FHWA) to work expeditiously  more PR

WASHINGTON, April 28 -- The U.S. Department of Defense issued the following news: * * * Contracts for April 28, 2025 ARMY General Dynamics Ordnance and Tactical Systems Inc., St. Petersburg, Florida, was awarded a $727,803,978 firm-fixed-price contract to procure 120 mm Insensitive Munition High Explosive with Tracer tank ammunition cartridges. Bids were solicited via the internet with one received. Work locations and funding will be determined with each order, with an estimated completion  more PR

WASHINGTON, April 28 -- The Environmental Protection Agency issued the following news release: * * * Administrator Zeldin Announces Major EPA Actions to Combat PFAS Contamination WASHINGTON - U.S. Environmental Protection Agency (EPA) Administrator Lee Zeldin outlined upcoming agency action to address Per- and Polyfluoroalkyl Substances (PFAS). In this suite of actions, Administrator Zeldin announced a long list that included in part the designation of an agency lead for PFAS, the creation of more PR

WASHINGTON, April 29 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Ecig Charleston LLC: * * * To: Ecig Charleston LLC, 1836 Ashley River Road, Suite Q1, Charleston, SC 29407, United States To Whom It May Concern, The Center for Tobacco Products of the U.S. Food and Drug Administration (FDA) recently reviewed our inspection records and determined that Ecig Charleston LLC manufactures, sells and/or distributes e-liquid p more PR

WASHINGTON, April 29 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Ecig South LLC: * * * To: Ecig South LLC, 7250 Rivers Avenue, Suite 7, Charleston, SC 29406, United States To Whom It May Concern: The Center for Tobacco Products of the U.S. Food and Drug Administration (FDA) recently reviewed our inspection records and determined that ECig Charleston manufactures, sells and/or distributes e-liquid products to customer more PR

WASHINGTON, April 29 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Alohma LLC, dba Kure CBD & Vape: * * * To: Alohma, LLC, d/b/a Kure CBD & Vape, 2390 North Diers Avenue, Grand Island, NE 68803, United States To Whom It May Concern: The Center for Tobacco Products of the U.S. Food and Drug Administration (FDA) recently reviewed our inspection records and determined that My Vapor Den Inc, d/b/a Nu Age Smoke & Vape sells more PR

WASHINGTON, April 29 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Silver Moon Nutraceuticals LLC, dba Mountain Vapor: * * * To: Silver Moon Nutraceuticals, LLC, d/b/a Mountain Vapor, 111 Fletcher Commercial Drive, Suite B, Fletcher, NC 28732, United States To Whom It May Concern: The Center for Tobacco Products of the U.S. Food and Drug Administration (FDA) recently reviewed our inspection records and determined that  more PR

WASHINGTON, April 29 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to My Vapor Den Inc. dba Nu Age Smoke & Vape: * * * To: My Vapor Den Inc, d/b/a Nu Age Smoke & Vape, 1006 North East End Boulevard Suite B, Marshall, TX 75670, United States To Whom It May Concern: The Center for Tobacco Products of the U.S. Food and Drug Administration (FDA) recently reviewed our inspection records and determined that My Vapor Den Inc, d/ more PR

WASHINGTON, April 29 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Sparky's Electronic Cigarettes: * * * To: Sparky's Electronic Cigarettes, 2060 West River Road, Tucson, AZ 85704, United States To Whom It May Concern: The Center for Tobacco Products of the U.S. Food and Drug Administration (FDA) recently reviewed our inspection records and determined that Sparky's Electronic Cigarettes manufactures, sells and/or distr more PR

WASHINGTON, April 29 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to NES21 LLC, dba Texas I-35 Vape: * * * To: NES21 LLC, d/b/a Texas I-35 Vape, 640 South Stemmons Street, Suite 200, Sanger, TX 76266, United States To Whom It May Concern: The Center for Tobacco Products of the U.S. Food and Drug Administration (FDA) recently reviewed our inspection records and determined that NES21 LLC, d/b/a Texas I-35 Vape manufactures more PR

WASHINGTON, April 29 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Vanity Vapor: * * * To: Vanity Vapor, 15557 West Roosevelt Street, Suite 105, Goodyear, AZ 85338, United States To Whom It May Concern: The Center for Tobacco Products of the U.S. Food and Drug Administration (FDA) recently reviewed our inspection records and determined that Vanity Vapor manufactures, sells and/or distributes e-liquid products to custom more PR

WASHINGTON, April 29 -- The U.S. Department of Health and Human Services Food and Drug Administration has released the following public communication dated April 7, 2025, from the College of American Pathologists: * * * To: The Honorable Martin A. Makary M.D., M.P.H. Commissioner US Food and Drug Administration (FDA) 10903 New Hampshire Avenue Silver Spring, MD 20993 Re: Artificial Intelligence Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendation more ST

WASHINGTON, April 29 -- The U.S. Department of Health and Human Services Food and Drug Administration has released the following public communication dated April 7, 2025, from the Connected Health Initiative: * * * To: Commissioner Martin Makary U.S. Food & Drug Administration Center for Devices and Radiological Health 10903 New Hampshire Ave Silver Spring, Maryland 20993-0002 RE: Comments of the Connected Health Initiative to the Food and Drug Administration, Draft Guidance for Industry  more ST

WASHINGTON, April 29 -- The U.S. Department of Health and Human Services Food and Drug Administration has released the following public communication dated April 7, 2025, from the Gerontological Society of America: * * * To: Food and Drug Administration 10903 New Hampshire Avenue Silver Spring, M.D. 20993 Re: Evaluation of Sex-Specific and Gender-Specific Data in Medical Device Clinical Studies; Draft Guidance for Industry and Food and Drug Administration Staff * * * On behalf of the Gero more ST

WASHINGTON, April 29 -- The U.S. Department of Health and Human Services Food and Drug Administration has released the following public communication dated April 4, 2025, from the Guttmacher Institute: * * * To: Commissioner of Food and Drugs Martin Makary, M.D., M.P.H. U.S. Food and Drug Administration 10903 New Hampshire Ave. Silver Spring, MD 20993 Re: Comment in Support of Citizen Petition FDA-2025-P-0377-0001 * * * Commissioner Makary, The Guttmacher Institute ("Guttmacher") submits more ST

WASHINGTON, April 28 -- The U.S. Department of Health and Human Services Food and Drug Administration has released the following public communication dated April 7, 2025, from the National Association of Manufacturers: * * * To: Jacqueline Corrigan-Curay, J.D., M.D. Acting Director, Center for Drug Evaluation and Research Food and Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993 Re: Docket FDA-2024-D-4689: Considerations for the Use of Artificial Intelligence to Supp more ST

WASHINGTON, April 28 -- Sen. Josh Hawley, R-Missouri, issued the following news release: * * * Hawley Calls on FDA to Reinstate Abortion Drug Safety Regulations: 'The Time to Act is Now' Today, U.S. Senator Josh Hawley (R-Mo.) sent a letter to Food and Drug Administration (FDA) Commissioner Marty Makary about new research showing that the safety risks of the chemical abortion drug mifepristone are far greater than the FDA currently acknowledges. Senator Hawley points to Dr. Makary's recent co more PR

CONCORD, New Hampshire, April 29 -- The New Hampshire Department of Insurance issued the following news release on April 28, 2025: * * * New Hampshire Insurance Department Updates Guidance for Licensee Disclosure Requirements The New Hampshire Insurance Department (NHID) has issued updated guidance to assist insurance producers and adjusters in meeting state-mandated disclosure requirements. The bulletin clarifies the options available to licensees for reporting formal public administrative a more PR

WASHINGTON, April 28 -- Rep. Chris Pappas, D-New Hampshire, issued the following news release: * * * Pappas Leads NH Congressional Delegation in Pressing for Urgent Risk Assessment of Portsmouth Memorial Bridge Following the Francis Scott Bridge tragedy last year, Portsmouth's Memorial Bridge was identified by NTSB to lack up-to-date vulnerability assessments Today Congressman Chris Pappas (NH-01), a member of the House Transportation and Infrastructure Committee, led Senator Jeanne Shaheen more PR